Source BioScience

Source BioScience is an international provider of integrated state of the art Laboratory Services. Headquartered in the UK, with offices in UK, Europe and the USA, Source BioScience is a fully owned subsidiary of SourceBio International plc, which listed on the AIM market of the London Stock Exchange in October 2020. Serving a variety of markets, our multidisciplinary expertise includes: Outsourced Histopathology Reporting Services & Human Tissue Testing Services; NGS (Next Generation Sequencing) & Sanger Sequencing Services; Stability Storage Solutions.